Log In
BCIQ
Print this Print this
 

docetaxel (MBP-Y004)

  Manage Alerts
Collapse Summary General Information
Company Mebiopharm Co. Ltd.
DescriptionTransferrin-conjugated nano particle formulation of Docetaxel
Molecular Target
Mechanism of Action 
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today